InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Yerxa Benjamin R. Director active across 2 companies, notably Clearside Biomedical, Inc.. Cumulatively, 7 reports have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €72k. History available since 15 May 2024. The latest transaction was disclosed on 23 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
YERXA BENJAMIN R is a declarant linked to Opus Genetics, Inc. and Clearside Biomedical, Inc. The 4 filings tracked cover the period from 2024-05-15 to 2026-04-27, with buys of EUR 18723 and sells of EUR 33483 in this recent sample. The modal transaction nature is Acquisition.